scholarly journals Early Clinical Indicators of Metabolic Syndrome and Insulin Resistance in A Cohort of Greek Children with Obesity

2020 ◽  
Vol 4 (1) ◽  
pp. 6-12
Author(s):  
Elpis Athina Vlachopapadopoulou ◽  
Eirini Dikaiakou ◽  
Elli Anagnostou ◽  
Fani Athanasouli ◽  
Ioanna Patinioti ◽  
...  
2016 ◽  
Author(s):  
Elpis Vlachopapadopoulou ◽  
Eirini Dikaiakou ◽  
Vasilis Petrou ◽  
Elli Anagnostou ◽  
Feneli Karachaliou ◽  
...  

2020 ◽  
Vol 79 (OCE2) ◽  
Author(s):  
Nataliia Samoilenko ◽  
Vira Khorunzha ◽  
Olga Bezugla ◽  
Karina Deineko ◽  
Marta Lisevych ◽  
...  

AbstractIntroductionMany studies have shown relationships between timing of food intake and insulin sensitivity. In addition to this, composition of food could be an important contributor to disruptions of the normal metabolism. The aim of this study was to assess the effect of diet composition and multiplicity on weight, body fat and insulin resistance in patients with metabolic syndrome (MS).Materials and MethodsWe tested 56 patients with MS (25 men and 31 women) who were 19 to 61 years of age. Patients were on 3-fold meal (food intake was at 8–9 a.m., 1–2 p.m. and 6–7 p.m.) with very low-carbohydrate (LC) breakfast and supper, lunch consisted of proteines (P), LC, polyunsaturated fatty acids (PUFAs) and non-starchy vegetables(V); there were no snacks during a day; diet intervension lasted 6 weeks. No drugs were used during this period. Body composition analysis was performed by bioimpedance analyzer (Omron BF511, Japan). Homeostatic model assessment-insulin resistance (HOMA-IR) was used to index IR. Self-reported diet records were used to assess dietary intake. Statistical analysis was based on using pair t-test with assessment of the dynamics of clinical indicators with 95% CI and calculation of the standardized effect size based on mean comparison (Cohen's d).Results46 patients (82,1%) completed the trial, physical activity didn't change substantially during this period. After 6-weeks BMI had reduced from 30,95 ± 5,31 kg/m2 to 29,14 ± 5,13 kg/m2 (treatment effect −1,81; 95%CI −2,25 to −1,37, p < 0,001). Mean body fat was 39,4 ± 7,87% at baseline, and 36,08 ± 8,72% after 6 weeks of diet, treatment effect −3,32; 95%CI −4,34 to −2,29, p < 0,001 - treatment effect was mostly observed among men (-4,9) than in women (-2,4). The most significant changes were observed in HOMA-IR score - it decreased from 4,03 ± 2,21 to 2,28 ± 1,37, treatment effect −1,74; 95%CI −2,29 to −1,21, p < 0,001 - treatment effect was also mostly observed among men (-2,46) than in women (-1,25).DiscussionOur findings demonstrate that this diet associated with statistically different changes in BMI, body fat and HOMA-IR. Individuals with obesity, particularly men, turned to group of overweight (BMI < 30kg/m2). Maximum effet size was in HOMA-IR changes - in 35 patients (76,1%) there were no insulin resistance markers after 6 week of diet intervention. So, 3-fold meal with very LC breakfast and supper, mixed lunch (LC + P + PUFAs + V), without any snacks could be good addition or even alternative to pharmacological treatment of MS.


Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1534-P
Author(s):  
DAVID P. CISTOLA ◽  
ALOK K. DWIVEDI ◽  
JAMY D. ARD

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1722-P
Author(s):  
MARTINA HÜTTL ◽  
IRENA MARKOVÁ ◽  
HANA MALINSKA ◽  
LUDMILA KAZDOVA ◽  
ONDREJ SEDA

2019 ◽  
Vol 17 (6) ◽  
pp. 595-603 ◽  
Author(s):  
Sezcan Mumusoglu ◽  
Bulent Okan Yildiz

The metabolic syndrome (MetS) comprises individual components including central obesity, insulin resistance, dyslipidaemia and hypertension and it is associated with an increased risk of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM). The menopause per se increases the incidence of MetS in aging women. The effect(s) of menopause on individual components of MetS include: i) increasing central obesity with changes in the fat tissue distribution, ii) potential increase in insulin resistance, iii) changes in serum lipid concentrations, which seem to be associated with increasing weight rather than menopause itself, and, iv) an association between menopause and hypertension, although available data are inconclusive. With regard to the consequences of MetS during menopause, there is no consistent data supporting a causal relationship between menopause and CVD. However, concomitant MetS during menopause appears to increase the risk of CVD. Furthermore, despite the data supporting the association between early menopause and increased risk of T2DM, the association between natural menopause itself and risk of T2DM is not evident. However, the presence and the severity of MetS appears to be associated with an increased risk of T2DM. Although the mechanism is not clear, surgical menopause is strongly linked with a higher incidence of MetS. Interestingly, women with polycystic ovary syndrome (PCOS) have an increased risk of MetS during their reproductive years; however, with menopausal transition, the risk of MetS becomes similar to that of non-PCOS women.


2011 ◽  
Vol 10 (8) ◽  
pp. 921-927 ◽  
Author(s):  
Shaheena Banu ◽  
Nasimudeen R. Jabir ◽  
C. N. Manjunath ◽  
Shazi Shakil ◽  
Mohammad A. Kamal

Sign in / Sign up

Export Citation Format

Share Document